BioStem Technologies Harnessing Perinatal Tissue for Regenerative Therapies

March 28, 2023

Fresh from a decision by the Center for Medicare Services to establish national pricing for its VENDAJE allografts for regenerative therapies, BioStem Technologies (OTCQB:BSEM) is gearing up for a new spurt of growth.

Follow link to read more: BioStem Technologies harnessing perinatal tissue for regenerative therapies - BioTuesdays

Subscribe To Our Newsletter

To stay up to date on all of our news, products, and achievements, please subscribe to our newsletter

Contact Information
(954) 380-8342

2836 Center Port Circle
Pompano Beach, FL 33064




© 2021 BioStem Technologies, Inc. All Rights Reserved. Use of this site is subject to certain Terms Of Use and Privacy Policy.
For screen reader problems with this website, please call (954) 380-8342 for assistance.